The Genomic Applications in Practice and Prevention Network

被引:41
作者
Khoury, Muin J. [1 ]
Feero, W. Gregory [2 ]
Reyes, Michele [1 ]
Citrin, Toby [3 ]
Freedman, Andrew [4 ]
Leonard, Debra [5 ]
Burke, Wylie [6 ]
Coates, Ralph [1 ]
Croyle, Robert T. [3 ]
Edwards, Karen [7 ]
Kardia, Sharon [2 ]
McBride, Colleen [2 ]
Manolio, Teri [2 ]
Randhawa, Gurvaneet [8 ]
Rasooly, Rebekah [9 ]
Pierre, Jeannette St. [1 ]
Terry, Sharon [10 ]
机构
[1] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA
[2] Natl Human Genome Res Inst, NIH, Bethesda, MD USA
[3] Univ Michigan, Ctr Community & Publ Hlth Genom, Ann Arbor, MI 48109 USA
[4] NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA
[5] Cornell Univ, Dept Pathol & Lab Med, New York, NY 10021 USA
[6] Univ Washington, Ctr Genom & Healthcare Equal, Seattle, WA 98195 USA
[7] Univ Washington, Ctr Genom & Publ Hlth, Seattle, WA 98195 USA
[8] Agcy Healthcare Res Qual, Rockville, MD USA
[9] NIDDK, NIH, Bethesda, MD USA
[10] Genet Alliance, Washington, DC USA
关键词
decision support; genomics; information; medicine; network; public health; EGAPP WORKING GROUP; OVARIAN-CANCER; UNITED-STATES; HEALTH-CARE; PROPHYLACTIC SURGERY; BREAST; RECOMMENDATIONS; WOMEN; SUSCEPTIBILITY; MORBIDITY;
D O I
10.1097/GIM.0b013e3181a551cc
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The authors describe the rationale and initial development of a new collaborative initiative, the Genomic Applications in Practice and Prevention Network. The network convened by the Centers for Disease Control and Prevention and the National Institutes of Health includes multiple stakeholders from academia, government, health care, public health, industry and consumers. The premise of Genomic Applications in Practice and Prevention Network is that there is an unaddressed chasm between gene discoveries and demonstration of their clinical validity and utility. This chasm is due to the lack of readily accessible information about the utility of most genomic applications and the lack of necessary knowledge by consumers and providers to implement what is known. The mission of Genomic Applications in Practice and Prevention Network is to accelerate and streamline the effective integration of validated genomic knowledge into the practice of medicine and public health, by empowering and sponsoring research, evaluating research findings, and disseminating high quality information on candidate genomic applications in practice and prevention. Genomic Applications in Practice and Prevention Network will develop a process that links ongoing collection of information on candidate genomic applications to four crucial domains: (1) knowledge synthesis and dissemination for new and existing technologies, and the identification of knowledge gaps, (2) a robust evidence-based recommendation development process, (3) translation research to evaluate validity, utility and impact in the real world and how to disseminate and implement recommended genomic applications, and (4) programs to enhance practice, education, and surveillance. Genet Med 2009:11(7):488-494.
引用
收藏
页码:488 / 494
页数:7
相关论文
共 31 条
  • [1] *AG HLTH RES QUAL, COMP BAS CLIN DEC SU
  • [2] [Anonymous], US SYST OV GEN TEST
  • [3] Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer
    Armstrong, K
    Micco, E
    Carney, A
    Stopfer, J
    Putt, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (14): : 1729 - 1736
  • [4] Recommendations from the EGAPP Working Group: can tumor gene expression in patients with breast cancer?
    Berg, Alfred O.
    Grp, E. G. A. P. P. Working
    Armstrong, Katrina
    Botkin, Jeffrey
    Calonge, Ned
    Haddow, James
    Hayes, Maxine
    Kaye, Celia
    Phillips, Kathryn A.
    Piper, Margaret
    Richards, Carolyn Sue
    Scott, Joan A.
    Strickland, Ora L.
    Teutsch, Steven
    [J]. GENETICS IN MEDICINE, 2009, 11 (01) : 66 - 73
  • [5] Berg AO, 2009, GENET MED, V11, P35, DOI [10.1097/GIM.0b013e318181fa2ff, 10.1097/GIM.0b013e31818fa2ff]
  • [6] Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?
    Berg, Alfred O.
    Armstrong, Katrina
    Borkin, Jeffrey
    Calonge, Ned
    Haddow, James
    Hayes, Maxine
    Kaye, Celia
    Phillips, Kathryn A.
    Piper, Margaret
    Richards, Carolyn Sue
    Scott, Joan A.
    Strickland, Ora L.
    Teutsch, Steven
    [J]. GENETICS IN MEDICINE, 2009, 11 (01) : 15 - 20
  • [7] Genetic testing for a BRCA1 mutation:: Prophylactic surgery and screening behavior in women 2 years post testing
    Botkin, JR
    Smith, KR
    Croyle, RT
    Baty, BJ
    Wylie, JE
    Dutson, D
    Chan, A
    Hamann, HA
    Lerman, C
    McDonald, J
    Venne, V
    Ward, JH
    Lyon, E
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 118A (03) : 201 - 209
  • [8] *CDCP, GEN APPL PRACT PREV
  • [9] Centers for Medicare & Medicaid Services, COV EV DEV
  • [10] *DEP HHS, 2008, PERS HEALTHC IN